Highlights
NASDAQ: MNLO       Menlo Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):1,561,259
4 Weeks Range:1.30 - 1.39
4 Weeks Price Volatility (%):
0.00%
52 Weeks Range:1.00 - 5.84
52 Weeks Price Volatility (%):
0.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Menlo Therapeutics Inc is a US-based late-stage biopharmaceutical company which focuses on the development and commercialization of Serlopitant for the treatment of pruritus associated with dermatologic conditions such as atopic dermatitis, psoriasis, and prurigo nodularis. The pipeline product of the company includes Prurigo Nodularis, Prurigo Dermatitis, Psoriasis and Refractory Chronic Cough.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

6239  2800  512  101 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00